Since MT5-MMP activates progelatinase A [40, 41] in tumor tissues and facilitates tumor progression [41], we then sought to explore whether SNCG-stimulated motility was mediated by activation of MMP-2. This evidence concerns the gene MMP2 and neoplasm.